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Abstract
Objectives To assess radiation exposure due to CT in the
Netherlands.
Methods Twenty-one hospitals participated in a dose survey
for the 21 most frequently used CT protocols. Hospitals
completed a Web survey with detailed parameters for one
patient per protocol, including the dose length product
(DLP) from the scanner dose report. Only standard-sized
patients (1.74 m and 77 kg and BMI 25.4 kg/m2±15 %) for
each protocol and available scanner were considered.
Effective dose (E) per protocol was estimated using ICRP-
103-based E/DLP coefficients. Dose levels were compared
to surveys from other countries and to diagnostic reference
levels.
Results Data of 186 patients (247 scan phases) from 14
hospitals and 19 scanners were used for final analysis of
DLP and E. Effective doses varied from 0.2 mSv in sinus
CT to 19.4 mSv for multiphase liver. The most frequent
exams were brain (1.5 mSv), abdomen (8.0 mSv), and
thorax-abdomen (11.5 mSv). These results are lower than
in Germany and comparable to those in the UK, and are
within reference levels. Results between hospitals varied,
with per protocol minimum/maximum E ratios ranging from
1.1–5.4.
Conclusions Compared to surrounding countries, CT in the
Netherlands is associated with relatively low radiation doses
in standard patients. Important differences remain between
hospitals.
Main Messages
• A national dose survey providing updated, detailed data
for patient dose in the most frequently used CT protocols.
• CT in the Netherlands is associated with relatively low
individual radiation doses in standard patients compared
to surrounding European countries.
• Considerable differences remain between hospitals for the
most frequently used CT protocols, indicating the need for
further optimisation.
Keywords Radiation dosage . Tomography . X-ray
computed . Health care surveys . Sievert units . Gray units
Introduction
Computed tomography (CT) is an important diagnostic im-
aging modality that plays a key role in medical diagnosis.
The number of CT examinations has shown a steady in-
crease, and recent reports estimate that in the USA 62
million examinations per year are performed with an esti-
mated growth of 8–10 % per year [1, 2]. In the USA, patient
exposures associated with medical imaging have become
the leading source of exposure of the population. In medical
imaging, CT is the most important contributor to patient
exposures [1–3].
In the European Union, member states are obliged to
survey dose data following Article 12 of EU Directive
97/43/Euratom. The last evaluation of measured CT doses
in the Netherlands was the “Demonstration Project Patient
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Dosimetry Radiology” (DP), which ran in 2001–2004 in 11
institutions, collecting specific data on 24 radiographic and
11 CT indications [5]. In subsequent years, only rough
estimations of population dose have been made based on
the information on the number of CT studies and type of CT
scans derived from yearly data collections of medical imag-
ing practice in the Netherlands. A disadvantage was that
these routine yearly data collections were based on financial
billing codes and not on actual practical clinical CT pro-
tocols or on CT dose assessment; therefore, they only
yielded basic data, limiting the usefulness for clinical prac-
tice or for feedback.
In the Netherlands in 2010, about 9.8 million diagnostic
imaging studies were performed using ionising radiation. Of
these, 1.16 million were CT studies, doubling the number
compared to 2002 (Figure 1). The average dose to the Dutch
population associated with medical imaging was estimated
to be 0.89 milliSievert (mSv). CT's contribution to this dose
was 0.42 mSv (47.5 %), while other big contributors were
angiography and interventions (22.3 %), conventional radi-
ography and mammography (17.6 %), and nuclear medicine
(11.0 %) [4]. Thus, while the above estimations were based
on the actual number of diagnostic studies in 2010, the
effective doses used for the estimations were taken from
the DP study [5].
This survey is similar in design to previous surveys
performed in Germany [6, 7] and the UK [8, 9]. But in
contrast to all but the newest UK survey, our protocols were
based on the frequency of use in clinical practice, and new
ICRP-103 conversion factors were used throughout.
The goal of the present survey was to renew the estima-
tion of patient dose from multidetector CT and to improve
the usefulness of the data for daily clinical practice by
collecting dose data on the most frequently used CT
protocols.
Materials and methods
Hospital and CT protocol selection
For this CT dose survey, a set of 21 hospitals was selected
randomly from all hospitals in the country with a balance
among general hospitals, categorical hospitals, and academ-
ic hospitals.
In an initial phase, the CT practice in these 21 participat-
ing hospitals was surveyed for a few days. The observed
practices resulted in a list of 21 CT protocols representing
the CT examinations responsible for more than 90 % of the
annual CT effective dose and more than 80 % of the number
of CT exams done in the Netherlands (Table 1). They
formed the basis for the subsequent CT part of the
National Survey on Radiation Dose (NSRD-CT).
Nationwide dose survey in CT
Based on the methodology used in the prior demonstration
project [5], a Web survey was developed together with the
data analysis department of the National Institute for Public
Health and Environment RIVM (RIVM, Bilthoven, the
Netherlands) from the Ministry of Health. A survey users'
guide was available to the participants, which included
detailed protocol descriptions for guidance.
The hospitals were asked to complete a Web survey with
detailed parameters for one standard-sized patient per proto-
col, including the dose length product (DLP) extracted from
the scanner dose report. For all scan phases of each protocol,
participants were required to record data on: (1) patient pa-
rameters [sex, weight, length, body mass index (BMI)], (2)
scanner type and parameters of the scan technique [tube
voltage (kV), tube current (mA), rotation time], and (3) type
and settings of automatic exposure control (AEC) and tube
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current modulation [TCM; noise index (NI), standard devia-
tion (SD), or reference mean effective tube load (mAs)].
Since the DLP was taken from the scanner dose report,
overrange was taken into consideration. We studied local
protocols for given clinical indications. In these local pro-
tocols, the kV could be variable per scan phase. Tube
current modulation techniques were employed as defined
in the local scan protocols.
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Fig. 2 Box plots of the
effective dose (mSv) of the
three most frequently used
CT protocols
Table 1 Dose results of CT protocols used in this national survey on CT radiation doses
Protocol name Clinical
indication
Relative
frequency (%)
Median scan
range (mm)
Median (P75)
DLP (mGy cm)
Median (P75)
E103 (mSv)
Ratio max/
min E
Brain Haemorrhage 23.8 155 813.7 (935.6) 1.5 (1.8) 3.3
Sinus Sinusitis 9.0 116 105.7 (133.4) 0.2 (0.3) 4.9
Neck Standard 2.3 252 329.9 (404.3) 1.7 (2.1) 2.2
Neck-thorax-abdomen Standard 0.7 880 985.1 (1,117.6) 13.8 (15.6) 1.7
Thorax Standard 6.6 313 320.0 (346.5) 4.6 (5.0) 2.8
Thorax-liver Lung cancer 4.1 401 542.0 (608.1) 8.1 (9.1) 2.7
Thorax-abdomen Standard 9.5 687 813.8 (885.7) 11.6 (12.6) 3.9
Thorax HR Interstitial Dz 3.1 273 142.8 (276.1) 2.1 (4.0) 13.4
Abdomen Standard 20.0 441 567.0 (618.0) 8.0 (8.7) 4.8
Abdomen low-dose Urolithiasis 2.1 399 301.6 (329.4) 4.5 (4.9) 3.3
CT urography Haematuria 2.8 452 708.0 (981.6) 10.0 (13.8) 2.5
Liver multiphasic Liver Tx 1.1 419 1,322.2 (1,496.6) 19.4 (22.4) 1.4
Pancreas multiphasic Adeno ca 0.6 409 899.0 (1,000.0) 13.2 (14.7) 2.0
Kidney multiphasic RCC 0.4 381 1,166.5 (1,371.2) 17.0 (20.2) 3.1
CT coronary angio CAD 1.5 125 516.5 (671.4) 13.5 (20.1) 3.0
CT pulmonary angio PE 4.8 279 291.5 (371.0) 4.2 (5.4) 2.7
CTA total aorta Dissection 0.7 666 822.5 (836.8) 11.7 (11.9) 1.1
CTA abdominal aorta AAA 1.8 474 555.5 (727.1) 7.8 (10.3) 3.8
C-Spine Standard 2.5 213 276.0 (320.9) 1.4 (1.6) 5.4
L-Spine Standard 1.5 171 308.2 (405.5) 4.3 (5.7) 3.2
Bony pelvis Standard 1.0 223 332.0 (382.1) 4.3 (4.9) 1.6
P75 75th percentile, DLP dose length product, E103 effective dose according to ICRP-103, Dz disease, Tx transplantation, ca carcinoma, RCC renal
cell cancer, CAD coronary artery disease, PE pulmonary embolism, AAA abdominal aortic aneurysm
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Patient selection
As effective dose has only been defined for normal-sized
patients, the average patient in the Netherlands [10] with a
margin ± 15 % was taken as a basis for patient selection.
Therefore, patients were only used in the final dose analysis
if their parameters were within the body weight range of
65.0–89.0 kg, body size of 1.61–1.87 m, and BMI of 21.6–
29.2 kg/m2.
Radiation dose parameters and calculations
Dose parameters such as (achieved) average effective mAs,
volume CT dose index (CTDIvol), and dose-length product
(DLP) were recorded for each scan phase from the dose
report. Effective dose (E) was estimated by multiplying the
DLP by recently established ICRP-103-based E/DLP coeffi-
cients for the relevant anatomical regions for multidetector CT
(for 120 kV: head 0.0019; neck 0.0051; thorax 0.0145; abdo-
men 0.0153; pelvis 0.0129; for the weighted averages for
multiregional scanning: neck-thorax 0.0134; thorax-
abdomen 0.0149; abdomen-pelvis 0.0141; thorax-abdomen-
pelvis 0.0142; neck-thorax-abdomen-pelvis 0.0138 [11]). In
comparison, values using ICRP-60 for 120 kV would have
been: head 0.0016; neck 0.0057; thorax 0.0136; abdomen
0.0155; pelvis 0.0167. The weighted averages for
multiregional scanning are: neck-thorax 0.0130; thorax-
abdomen 0.0145; abdomen-pelvis 0.0161; thorax-abdomen-
pelvis 0.0152; neck-thorax-abdomen-pelvis 0.0148 [11]. No
dosimetry measurements were performed on site.
Multiregional scanning
In multiregional scanning, given the clinical indication, the
anatomy can be scanned in either one scan (1 phase scan-
ning, 1P) or two separate scans (2 phase scanning, 2P).
Table 2 lists those patients scanned in one phase and those
in two separately. Differences in data come from differences
in overranging and from the use of slightly different E/DLP
conversion factors.
Data selection
Outliers for CTDIvol and DLP were excluded as follows:
for each protocol the median patient dose was calculated.
Data that resulted in a calculated patient dose for a given
protocol that was larger than five times the median value or
smaller than 0.2 times the median value were regarded as a
human report error and discarded from further data analysis.
Exclusion of these outliers will influence the ratio between
maximum and minimum E, but since we believe these to
represent report errors, this exclusion may render the per
protocol max/min E ratios more representative.
Statistical analysis
Box and whisker plots were used to visualise variations in the
radiation dose parameters. These profiles were characterised
by five parameters. The central line in the box represents the
median value, the edges of the box the 25th percentile (P25)
and 75th percentile, and the whiskers the minimum and max-
imum values. All calculations were performed with Excel
2011 for Mac (Microsoft, Redmond, WA, USA).
Results
In the intital practice survey phase, 5,017 studies were used
to construct the protocol Top-21. The relative frequency
figures of the Top-21 protocols are listed in Table 1. The
most frequently performed protocols were brain 23.8 %,
abdomen 20.0 %, and thorax-abdomen 9.5 %.
From the 21 participating hospitals with an installed base
of 30 scanners, 14 hospitals submitted complete and valid
data for 186 standard-sized patients (247 scan phases) on 19
scanners. Each protocol was characterised using data of an
average of nine scanners and an average of six hospitals per
protocol were used for final analysis of effective CT doses
of the 21 CT protocols. Three CT scanners were 4-row, five
were 16-row, one was 40-row, eight were 64-row, and two
were 128-row. Modern volumetric (3D) tube current modu-
lation techniques were employed in all scanners, except for
the four-row models. All image reconstruction was done
using filtered back projection techniques.
For the standard-sized patients, the established median
DLP and E doses ranged from a low of 105 mGy cm and
0.2 mSv for sinus CT to a high of 1322mGy cm and 19.4mSv
for multiphasic liver CT (Table 1 and 2). The most frequent
examinations were brain, abdomen, and thorax-abdomen CT,
which showed a modest median DLP of 814 mGy cm,
567 mGy cm, and 814 mGy cm, and median effective doses
of 1.5 mSv, 8.0 mSv, and 11.6 mSv, respectively (Figure 2).
The highest doses are observed for multiphasic oncology
CT protocols in the abdomen and for evaluation of tumours
in the liver and kidney. These were scanned in three to four
phases with a median DLP of 1,322 mGy cm and
1,167 mGy cm and corresponding median effective doses
of 19.4 mSv and 17.0 mSv. Another relatively dose-
intensive CT protocol is the lymphoma staging of the neck,
thorax, and abdomen with median DLP of 985 mGy cm and
E of 13.8 mSv.
For clinical indications in which contrast media timing is
not critical (lymphoma staging), hospitals have decided to
split long image ranges into two shorter helical acquisitions.
The dose penalty of this practice is limited but variable
(Table 2): For imaging of the neck, thorax, and abdomen,
the DLP is 1,104 mGy cm when the neck and thorax-
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abdomen are scanned separately versus 968 mGy cm for the
neck-thorax-abdomen scanned in one run. In contrast, for
imaging of the thorax and abdomen, the difference is only
790 mGy cm versus 769 mGy cm. Most differences lie in
differences in the extra dose from overranging [12, 13]. In
contrast, most of the dose increase is seen in imaging of the
Table 2 Dose results of individual phases used in this National Survey on Radiation Doses in CT
Protocol name Type scanning Median scan
range (mm)
Median (P75)
DLP (mGy cm)
Median (P75)
E103 (mSv)
Ratio max/min E
Brain S 160 806.0 (1,023.5) 1.5 (1.9) 3.3
H 146 901.6 (918.6) 1.7 (1.7) 1.1
Sinus H 116 106.4 (136.3) 0.2 (0.3) 4.9
Neck H 252 329.9 (404.3) 1.7 (2.1) 2.2
Neck–thorax-abdomen H 1P 872 968.1 (985.1) 16.2 (16.6) 1.3
H 2P Neck 241 280.0 (334.0) 1.4 (1.7) 1.5
H 2P Tx-Abd 648 824.0 (850.0) 11.7 (12.1) 1.4
Thorax H 313 320.0 (346.5) 4.6 (5.0) 2.8
Thorax-liver H 1P 396 383.0 (577.0) 5.7 (8.6) 2.3
H 2P Tx 320 279.7 (300.8) 4.1 (4.4) 1.6
H 2P Liver 241 277.4 (362.3) 4.2 (5.5) 2.1
Thorax-abdomen H 1P 630 764.5 (970.0) 10.9 (13.8) 3.7
H 2P Tx 293 279.1 (298.3) 4.0 (4.3) 4.6
H 2P Abd 437 511.3 (551.1) 7.2 (7.8) 2.5
Thorax HR S Insp 270 55.0 (55.0) 0.8 (0.8) 2.3
S Exp 160 4.0 (4.5) 0.1 (0.1) 1.5
H Insp 318 271.5 (378.4) 3.9 (5.5) 3.4
H Exp 301 19.9 (30.3) 0.3 (0.4) 4.4
Abdomen H Portal 441 567.0 (618.0) 8.0 (8.7) 4.8
Abdomen low dose H Unenhanced 399 301.6 (329.4) 4.5 (4.9) 3.3
CT urography H Unenhanced 412 328.0 (404.3) 4.6 (5.7) 5.7
H Nephrographic-excretory 452 490.3 (564.7) 6.9 (8.0) 1.8
Liver multiphasic H Unenhanced 240 265.6 (308.0) 4.1 (4.7) 1.6
H Arterial 237 337.0 (349.3) 5.2 (5.3) 2.0
H Portal 419 490.0 (677.5) 6.9 (9.6) 2.3
H Delayed 237 307.0 (372.2) 4.7 (5.7) 2.0
Pancreas multiphasic H Unenhanced 189 193.0 (224.0) 3.0 (3.4) 2.7
H Pancreatic 180 172.0 (242.0) 2.6 (3.7) 3.2
H Portal 409 464.0 (509.6) 6.5 (7.2) 1.8
Kidney multiphasic H Unenhanced 231 295.0 (346.3) 4.3 (5.3) 2.2
H Corticomed 202 391.0 (538.5) 5.7 (8.1) 4.8
H Nephrogenic 381 331.0 (351.0) 4.9 (5.1) 1.5
H Excretory 393 616.0 (623.0) 8.7 (8.8) 1.8
CT coronary angio S Calcium 140 48.1 (50.6) 1.4 (1.5) 1.6
H Arterial 125 492.4 (622.1) 14.8 (18.7) 2.7
CT pulmonary angio H Arterial 279 291.5 (371.0) 4.2 (5.4) 2.7
CTA total aorta H Arterial 666 822.5 (836.8) 11.7 (11.9) 1.1
CTA abdominal aorta H Arterial 474 555.5 (627.6) 7.8 (8.8) 2.0
C-Spine H Unenhanced 213 276.0 (320.9) 1.4 (1.6) 5.4
L-Spine H Unenhanced 171 308.2 (405.5) 4.3 (5.7) 3.2
Bony pelvis H Unenhanced 223 332.0 (382.1) 4.3 (4.9) 1.6
P75 75th percentile, DLP dose length product, E103 effective dose according to ICRP-103, Dz disease, S sequential, H helical, 1P one phase, 2P two
phases, Insp inspiration, Exp expiration, Tx thorax, Abd abdomen
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thorax and liver CT for lung carcinoma staging, with
557 mGy cm for the lung and liver scanned separately
versus 383 mGy cm for the thorax-liver in one run. This is
due to the fact that for the thorax a lower technique can be
chosen.
Ratios between maximum and minimum effective dose
ranged between 1.1 and 5.4 for most protocols, which is,
although considerably variable between institutions, well
within expected ranges seen in another survey [9]. The
incidental high figure for the ratio between the minimum
and maximum protocol dose can largely be attributed to
heterogeneity in examination techniques, such as when he-
lical vs. sequential HRCT of the lungs are considered to-
gether as one protocol.
Comparison of our data with other CT dose surveys is
given in Table 3. Doses are lower than established in the
German survey from 2001 [6] and of comparable value to
the results from the two most recent UK surveys [8, 9].
Additionally, when compared to older Dutch data [5], all
categories showed similar median values but lower mean
values.
The Netherlands Commission on Radiation Dosimetry
(NCRD) recently published diagnostic reference levels
(DRL), including potentially achievable levels after strict
dose optimisation [14]. Comparison of our results with
Dutch and other European DRLs [8, 15–17] is given in
Table 4.
Discussion
The dosimetric results of this survey represent the clinical
application of modern multidetector CT in the Netherlands.
Compared to surrounding countries, relatively moderate
doses are delivered for the most frequently performed CT
examinations. This has not substantially changed compared
to the Demonstration Project, which recorded data in 2001–
2004 [5].
In contrast to other surveys (except the one in Germany
[6]), we decided to gain data on a more specific level so that
after data analysis we could give focussed feedback to the
participating radiology departments. In the Netherlands many
Radiology Information Systems only record billing codes
(much fewer in number than the clinical scan protocols in
practical use), and therefore asking detailed questions resulted
in a relatively labour-intensive Web survey. In future surveys
we hope to make use of dose reports directly from the CT
scanners or from Hospital Information Systems.
It is not surprising that multiphasic abdominal tumour
protocols generate the highest doses. CT urography (CTU),
commonly regarded as dose intensive, was associated with a
modest dose since only split-bolus two-phase studies were
included. Using the data of CTU and renal cancer staging to
estimate a single bolus, three-phase CTU with all phases
covering the abdomen and pelvis would deliver a DLP in
excess of 1,300 mGy cm.
Table 3 Selected dose results of the national survey on radiation dose in CT and comparison with other studies
Protocol name NSRD 2010
DLP (mGycm)
NSRD 2010
E103 (mSv)
Brix 2002; DLP
(mGycm)
Brix 2002 E60
(mSv)
NRPB 2003 E60
(mGycm)
HPA 2008
E103 (mSv)
DP 2004
E60 (mSv)
Brain 813.7 1.5 1,016 2.8 1.7 1.4 1.2
Sinus 105.7 0.2 283 0.8 – – 0.2
Neck 329.9 1.7 302 2.0 – 3.0 –
Thorax 320.0 4.6 350 5.7 – 6.6 5.4
Thorax-liver 542.0 8.1 – – 6.8 7.0 –
Thorax–abdomen 813.8 11.6 1,027 17.8 10.0 10.0 –
Thorax HR 142.8 2.1 – – 1.5 1.2 1.6
Abdomen 567.0 8.0 790 14.4 7.8 6.7 7.7
Abdomen low dose 301.6 4.5 – – – 5.5 5.8
CT Urography 708.0 10.0 – – – 25.0 –
Liver multiphasic 1,322.2 19.4 – – – 14.0 –
CT coronary angio 516.5 13.5 583 10.5 – 16.0 –
CT pulmonary angio 291.5 4.2 310 5.4 – 3.3 4.1
CTA abdominal aorta 555.5 7.8 552 10.3 – 5.2 –
C-Spine 276.0 1.4 277 2.9 – 1.9 –
L-Spine 308.2 4.3 445 8.1 – 6.9 4.5
Bony pelvis 332.0 4.3 440 8.2 – 6.0 –
DLP dose length product, E103 effective dose according to ICRP-103, E60 effective dose according to ICRP-60, NSRD this study, Brix 2002=[6];
NRPB 2003=[8]; HPA 2008=[9]; DP 2004=[5]
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In studies with similar clinical indications in which con-
trast medium administration was not critical, the dose effect
of splitting long image ranges into two separate helical
acquisitions was variable. The higher increase in thorax-
liver CT is probably due to the difference in imaging re-
quirements between thorax and liver, whereby a split proto-
col is better suitable to serve both most adequately. It should
be noted that for different clinical indications in which
contrast timing is critical, replacing two separate acquisi-
tions with a combined acquisition may not be possible.
Our survey design is most comparable to the German
survey by Brix et al. [6]. The doses are lower than in that
particular survey for almost all protocols. Compared to the
data published by Shrimpton et al. [8] and Wall et al. [9]
from the UK, which is one of the countries with the lowest
CT doses worldwide, CT doses in the Netherlands are very
similar.
It should be taken into account that we used the published
E/DLP conversion factors derived using the ICRP-103
weighting factors [11]. Use of ICRP-60 factors would
change the results, but the level of change depends on the
specific protocol. For equal DLP, head CT protocols would
result in a 16 % lower effective dose, neck CT protocols in a
12 % higher effective dose, thorax CT protocols in a 7 %
lower effective dose, abdomen CT protocols in an
unchanged dose, and pelvic CT protocols in a 30 % higher
dose (abdomen-pelvis 14 % higher).
The similarity in the data of this survey compared to its
predecessor [5] indicate, however, that during that period
the more liberal use of CT and expansion of CT indications
have been balanced with newer technology for dose optimi-
sation such as volumetric tube current modulation and in-
teractive collimation to reduce overranging.
Only a few hospitals in this small sample exceed the DLP
set as the reference dose level for CT abdomen, but more
than 25 % exceed the level set for CT pulmonary angiogra-
phy. An integral part of this survey was feedback at the
protocol level as a counterattack against this variability and
lower doses nationwide. The best management strategy for
this feedback will be a topic for future study.
Comparison of our data with other CT dose surveys is
given in Table 3. Doses are lower than established in the
German survey from 2001 [6] and of comparable value to
the results from the two most recent UK surveys, published
in reports NRPB-W67 [8] and HPA-CRCE-12 [9].
Additionally, when compared to older Dutch data [5], all
categories showed similar median values but lower mean
values, indicating a trend to improvement in patient doses.
Comparison of the results of the survey with Dutch and
other European DRLs [8, 15–17] is given in Table 4. The
values of our DLP data are still above the achievable levels
set in the Dutch DRL report [14], indicating that the hospi-
tals included in this pilot survey can improve patient dose by
optimising their CT protocols and by upgrading to more
dose-efficient hardware.
Obviously, the biggest drawback to the survey was the
labour intensity of the Web survey for the participating
hospitals. Therefore the response to this pilot was relatively
limited and only two-thirds of hospitals participated.
Second, there was an inherent lack of control of the data
because manpower was limited to monitor data submission.
While 14 hospitals submitted data, many entries were in-
complete or partly invalid and not all hospitals contributed
in the same way to all the protocols. Third, use of the
effective dose is only defined for subjects with a normal
BMI, and our results only apply to normal-sized or mildly
Table 4 P75 dose results of this study compared to adult DRL in CT across Europe and Canada
Protocol name NSRD P75 DLP
(mGy cm)
NL 2012
DRL DLP
(mGycm)
NL 2012
achievable DLP
(mGycm)
F 2011
DRL DLP
(mGycm)
D 2010
DRL DLP
(mGycm)
UK 2003
DRL DLP
(mGycm)
CAN 2005 DRL
DLP (mGycm)
Brain 935.6 – – 1,050 950 930 1,300
Sinus 133.4 – – – 100 – –
Thorax 346.5 – – 475 400 – 600
Thorax-liver 608.1 – – – – 580 –
Thorax-abdomen 885.7 – – 1,000 – 940 –
Thorax HR 276.1 – – – – 170 –
Abdomen 618.0 700 400 800 900 560 1,100
CT coronary angio 671.4 1,000 300* – – – –
CT pulmonary angio 371.0 350 200 – – – –
L-Spine 405.5 – – 700 500 – –
Bony pelvis 382.1 – – – 450 – –
P75 75th percentile, DRL diagnostic reference level, DLP dose length product, NSRD this study, NL 2012=[14]; F 2011=[15]; D 2010=[16];
UK2003=[8]; CAN 2005=[17]
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obese patients. In slim patients and in patients with severe or
malignant obesity, these results may vary proportionally.
In conclusion, in this CT part of the National Radiation
Dose Survey, our detailed data show a moderate dose level
in CT in comparison with surrounding countries, which has
been stable over the past decade. The variability between
hospitals indicates that there is still room for optimisation,
whereby the details of our data may allow for more practical
feedback than possible before.
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